Global Information
회사소개 | 문의 | 비교리스트

중국의 알츠하이머병 치료제 시장

Alzheimer Disease Drugs Markets in China

리서치사 Asia Market Information & Development Co.
발행일 2019년 10월 상품 코드 86316
페이지 정보 영문 239 Pages
가격
US $ 4,000 ₩ 4,971,000 PDF by E-mail (Single User License)
US $ 8,000 ₩ 9,943,000 PDF by E-mail (Corporate Use License)


중국의 알츠하이머병 치료제 시장 Alzheimer Disease Drugs Markets in China
발행일 : 2019년 10월 페이지 정보 : 영문 239 Pages

중국의 알츠하이머병 치료제 수요는 과거 10년동안 급속히 상승했고 앞으로 5년간도 생산, 수요 모두 꾸준한 상승세를 이어갈 것입니다.

중국 알츠하이머병 치료제 시장의 투자 환경, 산업의 발전, 수요 및 공급, 산업 구조, 시장 진출 경로, 주요 기업, 실적과 장기 예측을 전해드립니다.

    제1장 서론
    • 본 보고서의 범위 및 방법론
    • 개요
    제2장 비즈니스 환경
    • 경제 전망
      • 주요 경제지표
      • 공업 생산량
      • 인구 및 노동력
      • 해외에서의 투자
      • 해외 무역
    • 금융 및 세금의 규제
      • 은행 제도 및 규제
      • 외환
      • 세금, 관세 및 세관
    제3장 알츠하이머병 치료제 산업 평가
    • 산업 구조
    • 시장 규모
    • 시장 성장 촉진요인
    • 매출
    • 주요 제조사의 설비 거점 및 매출
    • 주요 제조사의 시장 점유율
    • 노동 비용
    • 잠재성 있는 시장 진출기업
    • 주요 유통 기업
    • 해외에서의 주요 투자
    • 기술 개발
    제4장 알츠하이머병 치료제 생산 및 수요
    • 개요
    • 지역별 수요
    • 매출 및 수입량
      • Ginkgo Bilota Extract
      • Breviscapine
      • Ganglioside
      • Donepezil
      • Galanthamine
      • Nicergoline
      • Rivastigmine
      • Memantine
      • Huperzine A
      • Oxiracetam
      • Flunarizine
      • Piracetam
      • 기타
    • 가격 동향
    제5장 알츠하이머병 치료제 시장 전망
    • 시장 전망
    • 정부의 규제
    • 의료보험 산업의 전망
    • 소비자 지출 동향
    • 인구 동태
    • 의료 산업 동향
    • 병원 및 병상
    • 의사 및 왕진
    제6장 시장 전략
    • 중국 시장 진출 개요
      • 유통 시스템
      • 알츠하이머병 치료제의 유통 경로
      • 수송 인프라
      • 통신
    • 중국 시장 진출
      • 대중국 수출
      • 간접 수출
      • 직접 수출
      • 라이선스 및 제휴 제조
      • 중국내 구조
      • 제휴 제조
      • 무역 허가
      • 투자
      • 자본 제휴
      • 공동 제휴
      • 완전 외국 자본 기업
    제7장 알츠하이머병 치료제 제조사 디렉토리
    • 제조사 개요
    • 유통업체 및 무역회사
    • 협회 및 연구 기관
    • 주요 최종사용자
    도표 목록
pmh 09.05.13

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2008, 2013 and 2018) and long-term forecasts through 2023 and 2028 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investments
  • Technology Development

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Overview
  • Demand of Alzheimer's Disease Drugs by Region
  • Alzheimer's Disease Drugs Sales Volume
  • Ginkgo Bilota Extract
  • Breviscapine
  • Ganglioside
  • Donepezil
  • Galanthamine
  • Nicergoline
  • Rivastigmine
  • Memantine
  • Huperzine A
  • Oxiracetam
  • Flunarizine
  • Piracetam
  • Other Alzheimer's Disease Drugs
  • Alzheimer's Disease Drugs Imports
  • Ginkgo Bilota Extract Imports
  • Breviscapine Imports
  • Ganglioside Imports
  • Donepezil Imports
  • Galanthamine Imports
  • Nicergoline Imports
  • Rivastigmine Imports
  • Memantine Imports
  • Huperzine A Imports
  • Oxiracetam Imports
  • Flunarizine Imports
  • Piracetam Imports
  • Other Alzheimer's Disease Drugs Imports
  • Pricing Trend

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Alzheimer's Disease Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends By Region
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

V. MARKETING STRATEGIES

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. ALZHEIMER'S DISEASE DRUGS PRODUCER DIRECTORY

  • Major Alzheimer's Disease Drugs Producer Profiles
  • Distributors and Trading Companies
  • Associations and Research Institutes
  • Major End-Users

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Alzheimer's Disease Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investments

IV. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND DEMAND

  • Total Alzheimer's Disease Drugs Sales Volume
  • Alzheimer's Disease Drugs Major Producer and Their Market Share
  • Ginkgo Bilota Extract Major Producer and Their Market Share
  • Breviscapine Major Producer and Their Market Share
  • Ganglioside Major Producer and Their Market Share
  • Donepezil Major Producer and Their Market Share
  • Galanthamine Major Producer and Their Market Share
  • Dihydroergotamine Major Producer and Their Market Share
  • Rivastigmine Major Producer and Their Market Share
  • Memantine Major Producer and Their Market Share
  • Huperzine A Major Producer and Their Market Share
  • Oxiracetam Major Producer and Their Market Share
  • Flunarizine Major Producer and Their Market Share
  • Piracetam Major Producer and Their Market Share
  • Alzheimer's Disease Drugs Import

V. ALZHEIMER'S DISEASE DRUGS MARKET OUTLOOK

  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • Alzheimer's Disease Drugs Sales Volume

II. BUSINESS ENVIRONMENT

  • China's GDP and Industrial Output
  • Industrial Output by Ownership
  • China's Imports and Exports

III. ALZHEIMER'S DISEASE DRUGS INDUSTRY ASSESSMENTS

  • Alzheimer's Disease Drugs Sales Volume

II. ALZHEIMER'S DISEASE DRUGS PRODUCTION AND

  • DEMAND
  • Alzheimer's Disease Drugs Sales Volume
  • Worldwide Alzheimer's Disease Drugs Demand by Region
  • Ginkgo Bilota Extract Sales Volume and Market Share
  • Breviscapine Sales Volume and Market Share
  • Ganglioside Sales Volume and Market Share
  • Donepezil Sales Volume and Market Share
  • Galanthamine Sales Volume and Market Share
  • Dihydroergotamine Sales Volume and Market Share
  • Rivastigmine Sales Volume and Market Share
  • Memantine Sales Volume and Market Share
  • Huperzine A Sales Volume and Market Share
  • Oxiracetam Sales Volume and Market Share
  • Flunarizine Sales Volume and Market Share
  • Piracetam Sales Volume and Market Share
  • Other Alzheimer's Disease Drugs Sales volume and market share
  • Alzheimer's Disease Drugs Import Volume
  • Ginkgo Bilota Extract Import Volume and Market Share
  • Breviscapine Import Volume and Market Share
  • Ganglioside Import Volume and Market Share
  • Donepezil Import Volume and Market Share
  • Galanthamine Import Volume and Market Share
  • Dihydroergotamine Import Volume and Market Share
  • Rivastigmine Import Volume and Market Share
  • Memantine Import Volume and Market Share
  • Huperzine A Import Volume and Market Share
  • Oxiracetam Import Volume and Market Share
  • Flunarizine Import Volume and Market Share
  • Piracetam Import Volume and Market Share
  • Other Alzheimer's Disease Drugs Import Volume and Market Share

VI. MARKETING STRATEGIES

  • China's Distribution Channel
Back to Top
전화 문의
F A Q